The Launch-HTN trial is the largest trial of an aldosterone synthase inhibitor completed in participants with uncontrolled or treatment resistant hypertension – – Lorundrostat 50 mg once daily ...

To help you anticipate all that TV has to offer across broadcast, cable and streaming, TVLine offers a curated list of premieres and finales in July.